Clinical trial
Study to Evaluate the Effect of Nicotinamide Riboside on Immunity
NCT02812238 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Evaluate the Effect of Nicotinamide Riboside on Immunity
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 23, 2016
- Completion date
- August 28, 2018
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, coronary artery disease, diabetes